Cohen & Steers, Inc.
NYSE:CNSAsset Management
+$0.63 today
- Market cap
- $3.45B
- Beta
- 1.23
- P/E (TTM)
- 24.8
- EPS (TTM)
- $3.03
- Dividend yield
- 3.44%
Volume 0.39M
Average 0.32M
CNS EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Cohen & Steers, Inc.NYSE: CNS
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $58.65M rose 13.0% year over year, ahead of the +10.0% change in trailing-twelve-month EBITDA. Sequentially, it fell 21.4% from the prior quarter. Over 3 fiscal years it compounded at -4.2% a year.
Context
- EBITDA amounted to 35.4% of revenue in FY2025, down 3.9 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $241.96M (+20.3%) for the fiscal year ending Dec 2026, a step up from the -1.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $58.65M-21.4% QoQ
- Last fiscal yearDec 2025
- $201.14M-1.1% YoY
- LTMSep 2026
- $236.44M+10.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +13.0% | +47.1% | +34.1 pp |
| 1 year | -1.1% | +20.3% | +21.4 pp |
| 3-year CAGR | -4.2% | +14.9% | +19.1 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 201.14M USD
- Year-over-year change
- -1.1%
- 4-year CAGR
- -7.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 201.14M | -1.1% |
| FY2024 | 2024-12-31 | 203.39M | +19.9% |
| FY2023 | 2023-12-31 | 169.62M | -25.7% |
| FY2022 | 2022-12-31 | 228.42M | -18.2% |
| FY2021 | 2021-12-31 | 279.28M | — |
EBITDA vs competitors
How CNS compares with its peers on the latest reported figures
- CNS's LTM Sep 2026 EBITDA of $236.44M is the 8th highest of the 10 companies compared; the peer median is $437.02M.
- Its year-over-year change of +10.0% is the 5th highest of 10, against a peer median of +2.4%.
- EBITDA amounts to 38.5% of revenue for CNS, versus a peer median of 38.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $689.34M | +32.0% | +8.7% | 43.2% | |
| LTM Jun 2026 | $672M | +17.1% | -24.6% | 9.6% | |
| LTM Jun 2026 | $591.68M | +11.6% | +10.6% | 30.5% | |
| LTM Sep 2026 | $484.41M | +2.4% | +14.1% | 38.5% | |
| LTM Jun 2026 | $437.02M | +68.3% | +52.9% | 75.4% | |
| LTM Sep 2026 | $387.22M | -35.1% | -6.5% | 58.0% | |
| LTM Jun 2026 | $343.43M | -51.1% | +2.9% | 100.0% | |
| LTM Sep 2026 | $236.44M | +10.0% | -4.2% | 38.5% | |
| LTM Jun 2026 | -$16.23M | -139.5% | — | 3.5% | |
| LTM Sep 2026 | -$86M | -127.7% | +63.9% | 9.6% | |
| Peer median (excluding CNS) | $437.02M | +2.4% | +9.7% | 38.5% | |
Competitors are the stored peer set for CNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 583.83M | 573.72M | 489.64M | 517.42M | 567.8M |
| Cost of Revenue | 271.33M | 291.76M | 254.35M | 275.12M | 241.28M |
| Gross Profit | 312.5M | 281.97M | 235.29M | 242.3M | 326.52M |
| Gross Margin | 53.5% | 49.1% | 48.1% | 46.8% | 57.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 48.03M | 54.83M | 66.7M | 60.14M | 71.23M |
| Operating Expenses | 52.13M | 66.03M | 70.81M | 69.42M | 148.78M |
| Depreciation & Amortization | 16.03M | 5.67M | 5.14M | 11.17M | 11.71M |
| EBITDA | 279.28M | 228.42M | 169.62M | 203.39M | 201.14M |
| EBITDA Margin | 47.8% | 39.8% | 34.6% | 39.3% | 35.4% |
| Operating Income | 260.37M | 215.94M | 164.48M | 172.88M | 177.74M |
| Operating Margin | 44.6% | 37.6% | 33.6% | 33.4% | 31.3% |
| Interest Income | 2.88M | 6.82M | 14.62M | 19.34M | 10.32M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 21.57M | (19.04M) | 15.77M | 36.66M | 26.89M |
| Income Before Tax | 281.94M | 196.9M | 180.25M | 209.54M | 204.63M |
| Pre-Tax Margin | 48.3% | 34.3% | 36.8% | 40.5% | 36.0% |
| Income Tax Expense | 55.79M | 47.41M | 43.64M | 46.75M | 47.23M |
| Net Income | 211.4M | 171.04M | 129.05M | 151.27M | 153.22M |
| Net Margin | 36.2% | 29.8% | 26.4% | 29.2% | 27.0% |
| EPS (Basic) | 4.38 | 3.51 | 2.62 | 3.00 | 2.99 |
| EPS (Diluted) | 4.31 | 3.47 | 2.60 | 2.97 | 2.98 |
| Weighted Avg Shares | 48.32M | 48.78M | 49.31M | 50.41M | 51.24M |
| Weighted Avg Shares (Diluted) | 49.09M | 49.3M | 49.55M | 50.94M | 51.64M |
Cohen & Steers, Inc.
NYSE:CNS
Intrinsic Alpha fair value
Locked
Current Price
$67.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.